Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression

Cancer Cell International

Volumn 8, Issue , 2008, Pages

  Ismail, Nawfal I ^a   Kaur, Gurjeet ^a   Hashim, Hasnah ^a   Hassan, Mohammed S ^a  

^a ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INVASION; CANCER STAGING; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE MICROARRAY;

EID: 44449147959     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-8-6     Document Type: Article

References (33)

1. Ember CR Ember M Encylopedia of Medical Anthropology: Health and Illness in the World's Cultures Topics Springer 2004:10-44.
2. Sara Rosenthal M Stopping Cancer at the Source Trafford Publishing 2001:10-22.
3. Miley WM The Psychology of Well Being Praeger/Greenwood 1999:190-210.
4. Ginex PK Frazzitta BL Bains MS Hanson J 100 Questions & Answers about Esophageal Cancer Jones and Bartlett Publishers 2005:2-12.
5. Oakley A Essays on Women, Medicine and Health Edinburgh University Press 1993:189-200.
6. Lim GCC Halimah Y Lim TO First Report of the National Cancer Registry: Cancer Incidence in Malaysia 2002 Kuala Lumpur: National Cancer Registry 2003.
7. Hassanien A Fuzzy rough sets hybrid scheme for breast cancer detection Image and vision computing 2007, 25:172-183. 10.1016/j.imavis.2006.01.026
8. United StatesCongress, Office of Technology Assessment Identifying Health Technologies That Work: Searching for evidence DIANE Publishing 1994:92-200.
9. Barro S Marín R Fuzzy Logic in Medicine Springer 2002:36-40.
10. Corner J Bailey CD Cancer Nursing: Care in Context Blackwell Publishing 2002:140-155.
11. Kamby C The pattern of metastasis in human breast cancer-methodological aspect and influence of prognostic factor Cancer Treat Rev 1990, 17:37-61. 10.1016/0305-7372(90)90075-Q 2224869
12. Joseph T Dipiro Terry L Hamilton SCW Wells BG Pharmacotherapy Handbook McGraw - Hill Professional 2005:610-620.
13. Warfield CA Bajwa ZH Principles & Practice of Pain Management McGraw-Hill Professional 2004:450-460.
14. Kim R Asaki A Toge T Current and future role of new adjuvant chemotherapy in operable breast cancer Clinical breast cancer 2005, 6(3):223-32 16137432
15. Chen SL Wu YS Shieh HY Yen CC Shen JJ Lin KH p35 is a regulator of the metastasis suppressor gene nm23-H Mol Carcinog 2003, 36(4):204-214. 10.1002/mc.10110 12669312
16. Martinez JA Prevot S Nordlinger B Nguyen TM Lacarriere Y Munier A Lascu I Vaillant JC Capeau J Lacombe ML Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumor stages Gut 1995, 37(5):712-720. 1382880 8549951 10.1136/ gut.37.5.712
17. Belev B Aleric I Vrbanec D Petrovecki M Unusic J Jakic-Razumovic J nm23 gene product expression in invasive breast cancer-immunohistochemical analysis and clinicopahtological correlation Acta Oncol 2002, 41(4):355-361. 10.1080/028418602760169406 12234027
18. Mao H Liu H Fu X Fang Z Abrams J Worsham MJ Loss of nm23 expression predicts distal metastasis and poorer survival for breast cancer Int J Oncol 2001, 18(3):387-391.
19. Ozeki Y Takishima K Mamiya G Immunohistochemical analysis of nm23/NDP kinase expression in human lung adenocarcinoma: Association with tumor progression in Clara cell type Jpn J Cancer Res 1994, 85(8):840-846. 7928630
20. Engel M Theisinger B Seib T Seitz G Huwer H Zang KD High levels of nm23-H1 and nm23- H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages Int J Cancer 1993, 55:375-9. 10.1002/ijc.2910550306 8375920
21. Gazzeri S Brambilla E Negoescu A Thoraval D Veron M Moro D Overexpression of nucleoside diphosphate/kinase A/nm23-H1 in human lung tumors: Association with tumor progression in squamous carcinoma Lab Invest 1996, 74:158-67. 8569178
22. Nakamori S Ishikawa O Ohhigashi H Kameyama M Furukawa H Sasaki Y Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: An association with lymph node metastasis and tumor invasion Clin Exp Metastasis 1993, 11:151-8. 10.1007/BF00114973 8383029
23. Steeg PS Bevilacqua G Kopper L Thorgeirsson UP Talmadge JE Liotta LA Evidence for a novel gene associated with low tumour metastatic potential J Natl Cancer Inst 1988, 80:200-4. 10.1093/jnci/80.3.200 3346912
24. Hirayama R Sawai S Takagi Y Mishima Y Kimura N Shimada N Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer J Natl Cancer Inst 1991, 83:1249-50. 10.1093/jnci/ 83.17.1249 1651398
25. Tokunaga Y Urano T Furukawea K Kondo H Kanematsu T Shiku H Reduced expression of nm23/NDP kinase-h1, but not nm23/NDP kinase-h2, is concordant with the frequency of lymph-node metastasis of human breast cancer Int J Cancer 1993, 55:66-71. 10.1002/ijc.2910550113 8102131
26. Xerri L Grob JJ Battyani Z Gouvernet J Hassoun J Bonerandi JJ nm23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival Br J Cancer 1994, 70:1224-8. 7981081
27. Yamaguchi A Urano T Goi T Takeuchi K Niimoto S Nakagawara G Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma Cancer 1994, 73:2280-4. 10.1002/ 1097-0142(19940501)73:9<2280::AID-CNCR2820730908>3.0.CO;2-3 8168032
28. Campo E Miquel R Jares P Bosch F Juan M Leone A Prognostic significance of the loss of heterozygosity of nm23-H1 and p53 genes in human colorectal carcinomas Cancer 1994, 73:2913-21. 10.1002/ 1097-0142(19940615)73:12<2913::AID-CNCR2820731207>3.0.CO;2-L 8199988
29. Royds JA Rees RC Stephenson TJ nm23: A metastasis suppressor gene? J Pathol 1994, 173:211-2. 10.1002/path.1711730302 7931840
30. Han S Yun IJ Noh DY Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein J Surg Oncol 1997, 65:22-27. 10.1002/ (SICI)1096-9098(199705)65:1<22::AID-JSO5<3.0.CO;2-Q 9179263
31. Bevilaqua G Sobel M Liotta L Steeg P Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with high lymph node involvement and other histopathological indicators of high metastatic potential Cancer Res 1989, 49:5185-5190. 2475243
32. Hennessy C Henry J May F Expression of the antimetastatic gene nm23 in human breast cancer: An association with good prognosis J Natl Cancer Inst 1991, 83:281-285. 10.1093/jnci/83.4.281 1994057
33. Bertheau P Steinberg SM Merino MJ C-erb B-2, p53, and nm23 gene product expression in breast cancer in young women: Immunohistochemical analysis and clinicopathologic correlation Hum Pathol 1998, 29:323-329. 10.1016/ S0046-8177(98)90111-3 9563780